Gabapentin Capsule
Product Images NDC 71205-317

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 71205-317). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Formula (Ab1e0185 B802 4cf2 A5d4 B71f27f1dcb0 00)

This text seems to be a medical record and includes information related to weight and serum creatinine level of a patient. The weight is expressed in kilograms (kg) and appears to be 72 kg. The serum creatinine level is expressed in milligrams per deciliter (mg/dL) and has a value of 140, which could indicate some kidney dysfunction if combined with other clinical factors. The notation "(085 for feral patients)" is not clear without additional context.*

FDA Label Image

71205-317-90 (Container100mg500cc)

This is a description of Gabapentin 100mg capsules manufactured by Proficient Rx LP. The capsules come in a package of 90, with the lot number 00000 and an expiry date of 00/00/00. Each capsule contains Gabapentin, USP 100mg, and is white in color with "AHD" imprinted on the cap and "100" on the body. The medication guide should be provided separately to each patient, and the medication should be kept out of reach of children. The product is manufactured by Strides Shasun Limited, Unit-I, located in Puducherry, India, and should be stored at 20°-25°C.*

FDA Label Image

Figure1 (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 01)

FDA Label Image

Image 1 (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 02)

This appears to be a chart or table related to medication dosing for managing pain, specifically using gabapentin. The Moan Pain Score is likely a rating scale for pain. The chart shows a 4-week dose titration period followed by a fixed dose period, with one group receiving gabapentin at a dose of 3600 mg/day and another group receiving a placebo. There is a column for "Weeks" which likely indicates the time frame for each stage of the study.*

FDA Label Image

Image 2 (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 03)

This table shows the mean pain score throughout a 4-week fixed dose period for two different groups: One receiving a placebo and the other group receiving Gabapentin at either 1800mg/day or 2400mg/day. No further information is available.*

FDA Label Image

Image 3 (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 04)

FDA Label Image

Image 4 (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 05)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.